Role of ecto-5'-nucleotidase in bladder function.

Area of Science:

• Urology
• Molecular Biology
• Physiology

Background:

• Purinergic signaling is crucial for bladder contractility and voiding.
• Dysfunctional purinergic signaling contributes to lower urinary tract symptoms (LUTS).
• Ecto-5'-nucleotidase (NT5E) dephosphorylates AMP to adenosine, activating A2b receptors for bladder smooth muscle (BSM) relaxation.

Purpose of the Study:

• To investigate the role of NT5E in regulating bladder function using Nt5e knockout (Nt5eKO) mice.
• To elucidate compensatory mechanisms in the Nt5eKO mouse bladder contributing to a milder phenotype than observed in A2b receptor knockout (A2bKO) mice.

Main Methods:

• Voiding spot assay and urodynamic studies to assess bladder function.
• Myography to evaluate BSM contractility.
• Analysis of purinergic and other receptor expression in Nt5eKO bladders.
• Investigation of additional ecto-nucleotidases, including ALPL.

Main Results:

• Nt5eKO mice exhibited increased voiding frequency, smaller voids, shortened voiding intervals, and decreased bladder compliance.
• BSM contractility was reduced in Nt5eKO mice.
• P2Y12 receptor was downregulated in Nt5eKO bladders, suggesting a negative feedback response.
• Urothelial alkaline phosphatase (ALPL) was significantly upregulated, potentially compensating for NT5E deletion.

Conclusions:

• NT5E plays a role in modulating BSM contraction and relaxation, impacting bladder function.
• Compensatory mechanisms, including P2Y12 downregulation and ALPL upregulation, mitigate the severity of voiding dysfunction in Nt5eKO mice.
• The bladder purinergic signaling network is complex, involving paracrine interactions between urothelium and BSM.